Banophen Capsule
Product Images NDC 68788-7830

1 FDA label image from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Banophen (NDC 68788-7830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diphenhydramine HCl Capsules Usp 50mg (21643c64 Figure 01)

Diphenhydramine HCl Capsules Usp 50mg (21643c64 Figure 01)
Banophen diphenhydramine HCL Capsules USP 50 mg carton label manufactured by Preferred Pharmaceuticals Inc. The label includes dosage strength information, drug warnings, storage instructions, and areas to record expiration date, lot number, and batch number. Directions are provided in English and Spanish advising not to drink alcohol while taking the capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.